Insider Selling: Cardlytics (NASDAQ:CDLX) CEO Sells $56,394.00 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 54,225 shares of the company’s stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $1.04, for a total value of $56,394.00. Following the completion of the sale, the chief executive officer owned 1,057,220 shares in the company, valued at approximately $1,099,508.80. This represents a 4.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Amit Gupta also recently made the following trade(s):

  • On Wednesday, April 1st, Amit Gupta sold 62,549 shares of Cardlytics stock. The shares were sold at an average price of $0.99, for a total value of $61,923.51.
  • On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total transaction of $41,997.87.
  • On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The stock was sold at an average price of $0.90, for a total transaction of $46,844.10.
  • On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Price Performance

Shares of CDLX opened at $1.13 on Friday. Cardlytics, Inc. has a 52-week low of $0.66 and a 52-week high of $3.28. The firm’s fifty day moving average is $0.90 and its two-hundred day moving average is $1.34. The stock has a market cap of $62.23 million, a PE ratio of -0.58 and a beta of 0.91.

Cardlytics (NASDAQ:CDLXGet Free Report) last issued its earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The business had revenue of $56.10 million during the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. As a group, research analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on CDLX. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Evercore set a $1.00 price target on Cardlytics in a research report on Friday, March 6th. Finally, Wall Street Zen raised Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday. Two research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $1.75.

Get Our Latest Report on CDLX

Institutional Investors Weigh In On Cardlytics

A number of hedge funds have recently modified their holdings of the company. Virtu Financial LLC acquired a new stake in Cardlytics during the fourth quarter worth about $39,000. Invesco Ltd. boosted its holdings in Cardlytics by 38.1% in the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after purchasing an additional 46,973 shares during the last quarter. Barclays PLC boosted its holdings in Cardlytics by 31,167.6% in the 4th quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after purchasing an additional 55,790 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Cardlytics in the 4th quarter valued at approximately $62,000. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Cardlytics by 15.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock worth $125,000 after buying an additional 14,273 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.